molecular tumor board
Pronunciation: mo-LEK-yu-lar TOO-mor bord
Also written as: MTB
A multidisciplinary meeting focused on interpreting complex genomic testing results and developing personalized treatment strategies for cancer patients.
Full Definition
The molecular tumor board has become an essential component of modern thoracic oncology practice, bringing together medical oncologists, pathologists, molecular geneticists, and other specialists to discuss complex cases with genomic testing results. These boards review comprehensive genomic profiling results, interpret variants of unknown significance, discuss treatment options for rare mutations, and consider clinical trial opportunities. In the era of precision medicine, molecular tumor boards ensure that patients receive optimal therapy based on their tumor's molecular profile while also identifying candidates for investigational treatments targeting novel genomic alterations.
Usage
Usage note: Distinguish from general multidisciplinary tumor boards which may not focus specifically on genomic findings.
In Context
- "The case was presented at molecular tumor board to discuss treatment options for the patient's BRAF non-V600E mutation." — Consultation documentation
- "Molecular tumor board recommended enrollment in a basket trial targeting NRG1 fusions based on the genomic results." — Treatment planning note